Data table |
ID |
ORF |
GENE_SYMBOL |
ACCESSION_STRING |
CHROMOSOMAL_LOCATION |
DESCRIPTION |
SPOT_ID |
orf19.10 |
CaO19.10 |
ALK8 |
orf19.10|CGDID|CAL0000502 |
chrR:1556788-1555241 |
Alkane-inducible cytochrome P450; catalyzes hydroxylation of lauric acid to hydroxylauric acid; overproduction causes fluconazole resistance in a wild-type background and causes multidrug resistance in a cdr1 cdr2 double mutant background |
|
orf19.100 |
CaO19.100 |
|
orf19.100|CGDID|CAL0002961 |
chr6:0195363-0194311 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1002 |
CaO19.1002 |
|
orf19.1002|CGDID|CAL0001015 |
chr1:2339615-2337723 |
Predicted ORF in Assemblies 19, 20 and 21; possibly spurious ORF (Annotation Working Group prediction) |
|
orf19.1005 |
CaO19.1005 |
|
orf19.1005|CGDID|CAL0001021 |
chr1:2342421-2340613 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1007 |
CaO19.1007 |
|
orf19.1007|CGDID|CAL0001024 |
chrR:1136516-1135458 |
Putative transcription factor with bZIP DNA-binding motif |
|
orf19.1008 |
CaO19.1008 |
|
orf19.1008|CGDID|CAL0001025 |
chrR:1136836-1137150 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1009 |
CaO19.1009 |
|
orf19.1009|CGDID|CAL0001026 |
chrR:1137137-1137457 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.101 |
CaO19.101 |
|
orf19.101|CGDID|CAL0002962 |
chr6:0195986-0197026 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1010 |
CaO19.1010 |
MNT3 |
orf19.1010|CGDID|CAL0001038 |
chrR:1138174-1139310 |
Protein with similarity to mannosyltransferases; transcription is elevated in cyr1, chk1, nik1, and sln1 homozygous null mutants; fungal-specific (no human or murine homolog) |
|
orf19.1011 |
CaO19.1011 |
|
orf19.1011|CGDID|CAL0001040 |
chrR:1141367-1139385 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1012 |
CaO19.1012 |
|
orf19.1012|CGDID|CAL0001042 |
chrR:1142658-1143119 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.102 |
CaO19.102 |
|
orf19.102|CGDID|CAL0002963 |
chr6:0198348-0197098 |
Predicted ORF in Assemblies 19, 20 and 21; possibly spurious ORF (Annotation Working Group prediction) |
|
orf19.1026 |
CaO19.1026 |
|
orf19.1026|CGDID|CAL0001085 |
chr1:0804071-0803079 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1027 |
CaO19.1027 |
PDR16 |
orf19.1027|CGDID|CAL0001086 |
chr1:0801804-0802913 |
Phosphatidylinositol transfer protein; increased transcription correlates with CDR1 and CDR2 overexpression and azole resistance; induced by fluphenazine, 17-beta-estradiol, ethynyl estradiol, nitric oxide; farnesol-downregulated in biofilm |
|
orf19.1028 |
CaO19.1028 |
|
orf19.1028|CGDID|CAL0001087 |
chr1:0799432-0798254 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1029 |
CaO19.1029 |
|
orf19.1029|CGDID|CAL0001088 |
chr1:0797230-0798162 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.103 |
CaO19.103 |
KAR5 |
orf19.103|CGDID|CAL0002964 |
chr6:0198748-0199125 |
Protein of unknown function; induced by alpha factor |
|
orf19.1030 |
CaO19.1030 |
|
orf19.1030|CGDID|CAL0001110 |
chr1:0796896-0795616 |
Predicted ORF in Assemblies 19, 20 and 21 |
|
orf19.1031 |
CaO19.1031 |
HMG1 |
orf19.1031|CGDID|CAL0001113 |
chr1:0793655-0790434 |
HMG-CoA reductase; enzyme of sterol pathway; inhibited by lovastatin; gene not transcriptionally regulated in response to lovastatin and fluconazole |
|
orf19.1032 |
CaO19.1032 |
SKO1 |
orf19.1032|CGDID|CAL0001116 |
chr1:0788367-0790213 |
Protein similar to S. cerevisiae Sko1p; mutation causes no obvious phenotype; induced by osmotic stress via Hog1p |
|